Reaction

Application Site Bruise reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 958 reports · 7 co-occurring drugs

As of the last recalculation, Application Site Bruise appears in 958 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is PEGFILGRASTIM (PRR 85.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Pegfilgrastim27785.485.6
Nicotine4625.925.9
Methylphenidate2418.418.5
Oxybutynin1914.414.4
Buprenorphine4811.811.8
Rotigotine710.610.6
Etonogestrel52.32.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.